Washington / care & cost guideAll desks ↓

Checks / compounding desk

What changes if the medicine is compounded?

Making a medicine to order, including mixing it, is called compounding. Ask why you need that version of the medicine.

Does made to order mean FDA-reviewed?

The federal drug review agency’s name is Food and Drug Administration; its initials are FDA.

A compounded medicine is not approved by the FDA, as of September 2026.

Before it is offered, the agency does not check whether it works, how well it was made or what harm it may cause.

Making a medicine to order can meet a patient need that an approved product cannot meet.

Does a lower price settle whether a copy is allowed?

Federal law, as of September 2026, restricts copying an available medicine on a regular basis or in large quantities. It also matters whether the licensed person writing your prescription has identified a change that makes a real medical difference for you.

A change that meets your particular medical need can matter under this rule; a cheaper price alone does not.

Ask why this medicine is being made for you in particular.

Are semaglutide and tirzepatide still in national shortage?

As of September 2026, the FDA’s national shortage list includes neither semaglutide injections nor tirzepatide injections.

A pharmacy being out of stock locally is not the same as the FDA listing a national shortage.

Does an added vitamin make it different enough?

As of September 2026, the FDA says semaglutide with an added vitamin can still count as a copy of an available medicine.

In this example, the approved medicine and the made-to-order version are both injections with similar amounts of semaglutide. Adding a vitamin alone does not settle whether the new version counts as a copy.

Ask the person writing your prescription what change meets your medical need. The name of the mixture does not answer that question.

What backs up the answer?

FDA / what was reviewed

Approval of the factory-made medicine does not approve a version mixed by a pharmacy. The FDA has not checked the made-to-order medicine before it is sold.

As of September 2026.

Read what FDA review covers

FDA / copies and shortages

National shortages had allowed pharmacies to make copies of these injections. As of September 2026, that shortage reason no longer applies to semaglutide or tirzepatide injections. Ask what reason allows your particular medicine to be made now.

As of September 2026.

Read the FDA’s policy explanation